Gene therapy aims to restore sight in rare inherited blindness
NCT ID NCT07303296
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a gene therapy called GS010 for people with Leber hereditary optic neuropathy (LHON), a genetic condition that causes rapid vision loss. Researchers will give the treatment as an injection into the eye at two different doses to see if it improves vision and mitochondrial activity. The trial involves 14 participants aged 15 or older who have vision loss in both eyes due to a specific ND4 gene mutation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEBER HEREDITARY OPTIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Hopital national des quinze-vingts
RECRUITINGParis, 75012, France
Contact Email: •••••@•••••
Contact